Nuveen’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-751,508
Closed -$17.8M 3316
2023
Q4
$17.8M Buy
751,508
+52,116
+7% +$928K 0.01% 1231
2023
Q3
$10.4M Buy
699,392
+400,517
+134% +$5.31M ﹤0.01% 1457
2023
Q2
$3.27M Buy
+298,875
New +$2.78M ﹤0.01% 2119
2022
Q2
Sell
-287,914
Closed -$924K 3548
2022
Q1
$924K Buy
287,914
+5,245
+2% +$16.5K ﹤0.01% 2843
2021
Q4
$897K Sell
282,669
-23,178
-8% -$88K ﹤0.01% 2894
2021
Q3
$1.17M Sell
305,847
-5,040
-2% -$19.9K ﹤0.01% 2935
2021
Q2
$1.35M Sell
310,887
-49,691
-14% -$220K ﹤0.01% 2882
2021
Q1
$1.64M Buy
360,578
+33,867
+10% +$182K ﹤0.01% 2706
2020
Q4
$1.88M Buy
326,711
+74,991
+30% +$568K ﹤0.01% 2547
2020
Q3
$1.82M Sell
251,720
-9,998
-4% -$53.5K ﹤0.01% 2429
2020
Q2
$913K Sell
261,718
-131,867
-34% -$381K ﹤0.01% 2653
2020
Q1
$583K Sell
393,585
-389,603
-50% -$654K ﹤0.01% 2720
2019
Q4
$1.53M Buy
783,188
+450,435
+135% +$1.69M ﹤0.01% 2527
2019
Q3
$1.7M Sell
332,753
-11,293
-3% -$68.4K ﹤0.01% 2477
2019
Q2
$2.46M Buy
+344,046
New +$3.9M ﹤0.01% 2338

Other funds holding CBAY